The trading of TCE (T Cell Engager) bispecific antibodies remains hot, and multinational pharmaceutical companies (MNCs) are still placing orders…
Browsing: BioTech
ZAGENO Forms a Strategic Partnership With Hatch.Bio Labs, a Premier Biotech Incubator Biotech startups often encounter administrative roadblocks on their…
Everest Medicines (HKG 1952, Everest, or the Company), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization…
– Officially Benefiting Mainland China Patients Everest Medicines (HKEX 1952.HK, Everest, or the Company), a biopharmaceutical company focused on the discovery,…
– by the National Medical Products Administration of China for the Treatment of Moderately to Severely Active Ulcerative Colitis Everest…
Cambridge Isotope Laboratories, Inc. (CIL) has successfully developed and implemented a game-changing benzene-d6 recovery program, addressing major pain points for manufacturers…
Officially Beginning to Benefit Asian Patients Everest Medicines (HKG: 1952, Everest, or the Company), a biopharmaceutical company focused on the…
As reported by the South China Morning Post today, Everest Medicines (HKEX 1952.HK) is accelerating its journey to become a…
Collaboration between Bascom Palmer Eye Institute and Provectus Biopharmaceuticals VisiRose, a clinical-stage biotechnology company, is introducing Rose Bengal Photodynamic Antimicrobial…
Patients in the low-dose cohort who have completed 36 weeks of treatment, 9 out of 11 (81.8%) achieved overall clinical…
Everest Medicines (HKG: 1952, Everest, or the Company), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization…
Hua Medicine (the Company, HKG: 2552) announced today that the Company has successfully completed a Phase I clinical trial on…
Hua Medicine (the Company, HKG: 2552) announced today that the Company has successfully completed its SENSITIZE study on the mechanism…
Significantly Boosting Market Penetration and Driving Valuation Reassessment On November 28, the National Healthcare Security Administration (NHSA) and the Ministry…
Marking Another Milestone in Commercialization Today, Everest Medicines announced that NEFECON(R) has received full approval from the Ministry of Food…
– Offering a New Option for Moderately to Severely Active Ulcerative Colitis Patients Everest Medicines (HKG: 1952, Everest, or the…
The 17th “C.C. Tan Life Science Award” ceremony was held at Shenyang Pharmaceutical University on October 9th. Dr. Chen Li,…
– Demonstrating Benefits of Berberine Ursodeoxycholate (HTD1801) HighTide Therapeutics, Inc. (HKG: 2511), a clinical stage biopharmaceutical company specializing in the…
Enhancing the Quality of Life for All, Commiting to Investing in Technology Upgrades, and Developing Pharmaceutical and Healthcare Product Innovations…
– Published in “Kidney 360” Magazine Everest Medicines (HKG: 1952, Everest, or the Company), a biopharmaceutical company focused on the…